BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie cash
Cash and short-term investments held at the end of each period.
BioVie's cash was $8.98M at Jun 30, 2026. For fiscal 2026 it was $8.98M, down 48.8% from the year before. Over ten years it grew 53.5% a year on average. The highest annual figure on record is $23.84M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $8.98M | -48.8% |
| FY2025 | Jun 30, 2025 | $17.54M | -26.4% |
| FY2024 | Jun 30, 2024 | $23.84M | +22.5% |
| FY2023 | Jun 30, 2023 | $19.46M | +4.4% |
| FY2022 | Jun 30, 2022 | $18.64M | +313.2% |
| FY2021 | Jun 30, 2021 | $4.51M | +12029.7% |
| FY2020 | Jun 30, 2020 | $37.20K | -89.1% |
| FY2019 | Jun 30, 2019 | $339.92K | +642.2% |
| FY2018 | Jun 30, 2018 | $45.80K | +791.1% |
| FY2017 | Jun 30, 2017 | $5.14K | -95.8% |
| FY2016 | Jun 30, 2016 | $123.76K | -53.7% |
| FY2015 | Jun 30, 2015 | $267.48K | -19.6% |
| FY2014 | Jun 30, 2014 | $332.86K | -34.2% |
| FY2013 | Jun 30, 2013 | $505.70K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $8.98M | -48.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $13.10M | -43.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $20.54M | -15.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $24.98M | +24.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $17.54M | -26.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $23.15M | -23.7% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $24.41M | +20.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $20.02M | -5.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $23.84M | +22.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $30.35M | -3.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $20.23M | -55.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $21.21M | -0.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $19.46M | +4.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $31.28M | +27.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $45.75M | +50.5% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $21.23M | +3.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $18.64M | +313.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $24.51M | +115.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $30.39M | +81609.0% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $20.49M | +55.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $4.51M | +12029.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $11.35M | +305452.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $37.20K | +1096.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $13.20M | +5199.2% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $37.20K | -89.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $3.72K | -99.6% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.11K | -99.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $249.01K | +443.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $339.92K | +1110.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $971.61K | +53168.3% |
| Q1 FY2019CQ3 2018 | Dec 31, 2018 | $1.63M | +7412.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $45.80K | +791.1% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $28.08K | -20.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $1.82K | -59.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $21.70K | +148.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $5.14K | -95.8% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $35.31K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $4.52K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $8.75K | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $123.76K | – |
See a number that looks wrong?